Ctmx shares
WebView the latest CytomX Therapeutics Inc. (CTMX) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebMar 28, 2024 · Cash, cash equivalents, and investments of $194 million exclude the $35 million cash payment received under the Moderna agreement in Q1 2024. Price Action: CTMX shares are down 15.10% at $1.52 on...
Ctmx shares
Did you know?
WebShares Sold Short 1.27 M Change from Last -7.69% Percent of Float 1.97% Stock Money Flow N/A PROFILE ( CTMX) CytomX Therapeutics, Inc. engages in the development of … WebApr 7, 2024 · See the latest CytomX Therapeutics Inc stock price (NASDAQ:CTMX), related news, valuation, dividends and more to help you make your investing decisions.
WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Rating) has received an average rating of "Hold" from the twelve analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and two have as Skip to main content S&P 500 … WebFair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. ... CTMX) Q4 2024 …
WebCytomX Therapeutics shares outstanding from 2014 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming … WebApr 10, 2024 · Stoke Therapeutics is trading at a lower price-to-earnings ratio than CytomX Therapeutics, indicating that it is currently the more affordable of the two stocks. Institutional and Insider Ownership...
WebEarnings Per Share: The trailing 12 months EPS from total operations is the bottom line income after all expenses, divided by the weighted average number of common shares …
WebMar 30, 2024 · CTMX stock opened at $1.54 on Thursday. The company has a market capitalization of $101.43 million, a PE ratio of -1.03 and a beta of 0.69. CytomX Therapeutics, Inc. has a 12 month low of $1.17... chkd interviewWebCTMX - Stock Price Chart CTMX [NASD] CytomX Therapeutics, Inc. Healthcare Biotechnology USA statements CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. grass masters algona iowaWebApr 14, 2024 · Shares of NASDAQ:CTMX opened at $1.73 on Friday. CytomX Therapeutics has a 12 month low of $1.17 and a 12 month high of $3.02. The business’s 50 day simple moving average is $2.01 and its 200 ... grass masters algonaWebCytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline … chkd lab locations suffolk vaWebApr 10, 2024 · NASDAQ:CTMX CytomX Therapeutics - CTMX Stock Forecast, Price & News $1.60 +0.04 (+2.56%) (As of 04/10/2024 12:00 AM ET) Compare Today's Range … grass master ponchatoulagrassmaster pay my billWebMar 20, 2024 · Shares of NASDAQ:CTMX opened at $1.86 on Monday. The company has a market capitalization of $122.91 million, a price-to-earnings ratio of -1.25 and a beta of 0.69. The business’s 50-day moving ... grassmasterslawns.com